ASHP Announces Candidates for Board of Directors

Published: April 20, 2022

The ASHP Committee on Nominations and the Board of Directors have approved the following ASHP members as candidates for ASHP elected offices:


  • Stephen F. Eckel, PharmD, MHA, FASHP, FAPhA, FCCP
    Associate Professor and Associate Dean, UNC Eshelman School of Pharmacy, Chapel Hill, NC
  • Nishaminy (Nish) Kasbekar, PharmD, BS, FASHP
    Chief Pharmacy Officer, Penn Presbyterian Medical Center, Philadelphia, PA

Board of Directors

  • Jill S. Bates, PharmD, MS, BCOP, CPT, FASHP
    National PHASER Pharmacy Program Manager, Department of Veterans Affairs, Durham, NC
  • Vickie L. Ferdinand-Powell, PharmD, MS, BS, RPh, FASHP
    Director of Pharmacy Operations, New York Presbyterian Hospital, New York, NY
  • JoAnn Stubbings, BS, MHCA, RPh
    Clinical Associate Professor Emerita, University of Illinois Chicago College of Pharmacy, Chicago, IL
  • Jennifer E. Tryon, PharmD, MS, FASHP
    Chief Pharmacy Officer, Henry Ford Health System, Detroit, MI


  • Christene M. Jolowsky, BSPharm, MS, FASHP, FMSHP
    Senior Director of Pharmacy, Hennepin Healthcare System, Minneapolis, MN
  • James A. Trovato, PharmD, MBA, FASHP
    Professor and Vice Chair of Academic Affairs and Administrator, Office of Continuing Education, University of Maryland School of Pharmacy, Baltimore, MD

Information about the backgrounds and perspectives of the candidates for President elect and Board of Directors will be available in June at  Online voting will begin on July 1.

Posted April 20, 2022

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information